标题
pEGFR-Tyr 845 expression as prognostic factors in oral squamous cell carcinoma
作者
关键词
-
出版物
CANCER BIOLOGY & THERAPY
Volume 13, Issue 11, Pages 967-977
出版商
Informa UK Limited
发表日期
2012-09-07
DOI
10.4161/cbt.20991
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Evaluation of a combined triple method to detect causative HPV in oral and oropharyngeal squamous cell carcinomas: p16 Immunohistochemistry, Consensus PCR HPV-DNA, and In Situ Hybridization
- (2012) Giuseppe Pannone et al. Infectious Agents and Cancer
- The role of tissue microarray in the era of target-based agents
- (2011) Renato Franco et al. Expert Review of Anticancer Therapy
- Significant association of SRC protein expression with the progression, recurrence, and prognosis of oral squamous cell carcinoma in Taiwan
- (2011) Shih-Jung Cheng et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- CD133/Src Axis Mediates Tumor Initiating Property and Epithelial-Mesenchymal Transition of Head and Neck Cancer
- (2011) Yu-Syuan Chen et al. PLoS One
- The role of human papillomavirus in the pathogenesis of head & neck squamous cell carcinoma: an overview
- (2011) Giuseppe Pannone et al. Infectious Agents and Cancer
- Phosphorylated AKT expression is associated with PIK3CA mutation, low stage, and favorable outcome in 717 colorectal cancers
- (2010) Yoshifumi Baba et al. CANCER
- Distinct Interactions Between c-Src and c-Met in Mediating Resistance to c-Src Inhibition in Head and Neck Cancer
- (2010) B. Sen et al. CLINICAL CANCER RESEARCH
- Epidermal growth factor receptor (EGFR) mutation and p-EGFR expression in resected non-small cell lung cancer
- (2010) Elizabeth McMillen et al. EXPERIMENTAL LUNG RESEARCH
- Association of Phosphorylated Epidermal Growth Factor Receptor with Survival in Patients with Locally Advanced Non-small Cell Lung Cancer Treated with Radiotherapy
- (2010) Theodoros Tsakiridis et al. Journal of Thoracic Oncology
- Effects of type I interferons on IGF-mediated autocrine/paracrine growth of human neuroendocrine tumor cells
- (2009) Giovanni Vitale et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Combined cetuximab and genistein treatment shows additive anti-cancer effect on oral squamous cell carcinoma
- (2009) Sung-Jin Park et al. CANCER LETTERS
- Emerging Strategies to Strengthen the Anti-Tumour Activity of Type I Interferons: Overcoming Survival Pathways
- (2009) M. Caraglia et al. CURRENT CANCER DRUG TARGETS
- Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
- (2009) James A Bonner et al. LANCET ONCOLOGY
- Epidermal growth factor receptor expression and gene copy number in sinonasal intestinal type adenocarcinoma
- (2009) Alessandro Franchi et al. ORAL ONCOLOGY
- EGFR Inhibitor Enhances Cisplatin Sensitivity of Oral Squamous Cell Carcinoma Cell Lines
- (2009) Yukihiro Hiraishi et al. PATHOLOGY & ONCOLOGY RESEARCH
- Annual Report to the Nation on the Status of Cancer, 1975–2005, Featuring Trends in Lung Cancer, Tobacco Use, and Tobacco Control
- (2008) Ahmedin Jemal et al. JNCI-Journal of the National Cancer Institute
- Tumor Dependence on the EGFR Signaling Pathway Expressed by the p-EGFR:p-AKT Ratio Predicts Erlotinib Sensitivity in Human Non-small Cell Lung Cancer (NSCLC) Cells Expressing Wild-Type EGFR Gene
- (2008) Tianhong Li et al. Journal of Thoracic Oncology
- Low prevalence of human papillomavirus in squamous-cell carcinoma limited to oral cavity proper
- (2008) Luca Scapoli et al. MODERN PATHOLOGY
- Salivary gland-type lung carcinomas: an EGFR immunohistochemical, molecular genetic and mutational analysis study
- (2008) Ricardo S Macarenco et al. MODERN PATHOLOGY
- Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines
- (2008) Hervé Wallerand et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Cetuximab is Effective, but more Toxic than Reported in the Bonner Trial
- (2007) H.K. Lord et al. CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started